The 2025 International Workshop on Alport Syndrome

Published on 05/09/2025

5-7 September 2025
Beijing, China

ENYO Pharma will attend The 2025 International Workshop on Alport Syndrome, organized by Alport Syndrome Alliance.
It is an opportunity for the Alport community to connect, update and discuss the latest research.

ENYO Pharma will meet patients and their families to present its ongoing Phase 2 “ALPESTRIA-1” clinical study with Vonafexor in Alport syndrome patients.

https://www.alportsyndromealliance.org/

Read next in 'Events'

• ASN 2025 - American Society of Nephrology
• The 2025 International Workshop on Alport Syndrome
• ASN - the American Society of Nephrology 2025
• BIO International Convention
• Alport Connect 2025, la rencontre annuelle américaine avec les patients atteints du syndrome d’Alport